NewsBenzingaOPKO Biologics在其用于治疗肢端肥大症的OPK-8801001 1/2a期临床研究中完成首例患者给药 OPKO Biologics在其用于治疗肢端肥大症的OPK-8801001 1/2a期临床研究中完成首例患者给药 Benzinga 2026.10.27 12:07 (GMT+0) Open on Benzinga Other news Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’ CoreWeave’s stock pops — even as Nvidia talks up a ‘disciplined’ approach to financing Asia stocks set to snap losing streak on Nvidia beat as Anthropic looms Nvidia’s startup stakes ballooned to $65B, but Huang’s exit puts future deals in doubt agilon health, inc. (AGL) Driving Performance at Scale: Technology-Enabled Clinical and Quality Programs Transcript
Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain
Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’
agilon health, inc. (AGL) Driving Performance at Scale: Technology-Enabled Clinical and Quality Programs Transcript